BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  QT Imaging Holdings Announces Shipment of Six QT Breast Acoustic CT Scanners in the First Quarter of 2025

  April 2, 2025

   · 

  3 min read
• Press Releases

  GRI Bio Reports Encouraging Interim 2-Week Safety Results from Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)

  April 2, 2025

   · 

  8 min read
• Press Releases

  Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement

  April 2, 2025

   · 

  5 min read
• Press Releases

  Andrew H. Weinstein, MD, MPH, FAAD, elected American Academy of Dermatology president for 2027

  April 2, 2025

   · 

  2 min read
• Press Releases

  Inhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and President

  April 2, 2025

   · 

  8 min read
• Press Releases

  Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 1, 2025

  April 2, 2025

   · 

  1 min read
• Press Releases

  Johnson & Johnson Announces Expected Closing Date for Intra-Cellular Acquisition

  April 2, 2025

   · 

  4 min read
• Press Releases

  Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - April 1, 2025

  April 2, 2025

   · 

  2 min read
• Press Releases

  Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis

  April 2, 2025

   · 

  12 min read
• Press Releases

  Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 1, 2025

  April 2, 2025

   · 

  2 min read